Concepedia

Kevin B. Sippy

KB

Statistics

Publications

8

Citations

258

H-Index

8

Active since

1997

Affiliations

Abbott Fund(Current)

Abbott (United Kingdom)

Abbott (United States)

Kevin B. Sippy is an author at Abbott Fund specializing in medicinal chemistry, pharmacology, and ligand binding.

Publications per year

1997–2012

8

Publications

8

Synthesis and Structure−Activity Relationship Studies of 3,6-Diazabicyclo[3.2.0]heptanes as Novel α4β2 Nicotinic Acetylcholine Receptor Selective Agonists

Jianguo Ji, Michael R. Schrimpf, Kevin B. Sippy et al. · Journal of Medicinal Chemistry · 2007 · 46 citations · Full text

, , +17

Structure−Activity Studies for a Novel Series of Tricyclic Substituted Hexahydrobenz[<i>e</i>]isoindole α<sub>1A</sub> Adrenoceptor Antagonists as Potential Agents for the Symptomatic Treatment of Benign Prostatic Hyperplasia (BPH)

Michael D. Meyer, Robert J. Altenbach, Fatima Z. Basha et al. · Journal of Medicinal Chemistry · 2000 · 43 citations

, , +17

SAR of α7 nicotinic receptor agonists derived from tilorone: Exploration of a novel nicotinic pharmacophore

Michael R. Schrimpf, Kevin B. Sippy, Clark A. Briggs et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 34 citations · Full text

, , +13

Structure−Activity Studies for a Novel Series of<i>N</i>-(Arylethyl)-<i>N</i>-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-<i>N</i>-methylamines Possessing Dual 5-HT Uptake Inhibiting and α<sub>2</sub>-Antagonistic Activities

Michael D. Meyer, Arthur A. Hancock, Karin Tietje et al. · Journal of Medicinal Chemistry · 1997 · 34 citations · Full text

, , +17

Structure−Activity Studies for a Novel Series of Bicyclic Substituted Hexahydrobenz[<i>e</i>]isoindole α<sub>1A</sub> Adrenoceptor Antagonists as Potential Agents for the Symptomatic Treatment of Benign Prostatic Hyperplasia

Michael D. Meyer, Robert J. Altenbach, Hao Bai et al. · Journal of Medicinal Chemistry · 2001 · 33 citations · Full text

, , +17

1–5 of 8